Close Menu

NEW YORK (GenomeWeb) – Transgenomic said today that it has received $1.15 million in proceeds from a note bridge financing.

The company will use the funds to complete its merger with Precipio Diagnostics, which is expected to close in the second quarter. The companies announced the intended merger, which will make Precipio a wholly owned subsidiary of Transgenomic, in October.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.

May
22

This webinar will outline the entire liquid biopsy workflow from cell-free DNA isolation to mutation detection by Crystal Digital PCR with the Naica System from Stilla Technologies.